Work with us
International Business Area
R+D / Regulatory
R+D / Regulatory
RJ Barcelona plant
RJ Acquired the Sant Joan Despí site (Barcelona) in 1998, with three independent buildings and a surface of 23,000m2
Investment made in 2000 to renovate the production building and offer production services for third parties of:
Sterile freeze-dried vials
Sterile ampoules and vials
Liquid forms: oral and topic solutions, syrups, single-dose liquid forms and impregnated wipes.
Semi-solid forms: ointments, emulsions, micro-emulsions, creams
Oral solid forms: capsules, pills, tablets and coated tablets
Increase in the production capacity in 2008 of oral and topic solutions (alcoholic and non-alcoholic) with the creation of a new production area.
- 2,000 and 8,000 litre reactors in the ATEX/GMP area.
- 6,000 litre reactors in the Conventional/GMP area.
5,000,000 litre capacity.
An important and specialised investment beginning in 2008 aimed at increasing the lyophilisation (freeze-drying) capacity threefold (x 3) during 2008-2009.
5 freeze-dryers available in different sizes from 0,1 xm2 to 23 m2.
Capacity for 10,000,000 lines of freeze-dried vials pa.
Creation of a
Center of Excellence in Lyophilization
in 2008, with a substantial investment in technical and human resources (Differential Scanning Calorimetry (DSC), Freeze-Dryer Microscopy and DTA-ER), which will enable the development of freeze-drying vial products for Pharmaceutical and Biological companies globally, using acquired experience and knowledge particularly in the optimisation of freeze-drying cycles.
RJ Toledo facility
RJ Acquired the site from SB (Smithkline Beecham, now GlaxoSmithkline) in 2000 for the purpose of specialising in the development of generic antibiotics and production of Penicillin specialities for third parties.
In 2003, RJ built a new independent facility on the land adjacent to the original site, to produce sterile Cephalosporin antibiotic vials.
RJ Toledo is currently made up of two completely independent facilities and installations with a surface of 21,000 m2.
Machinery and equipment to manufacture oral forms (oral suspensions, tablets, capsules, sachets and suspensions)
3 lines of sterile vials for injection and infusion.
2 lines of sterile powder vials
Continuous investments have made this one of the most advanced beta-lactam antibiotics (penicillin and cephalosporin) sites in Europe because of its specialisation, technology, production quality and production capacity (more than 70 million units a year). Production units have doubled and employee numbers have grown substantially since the facility was acquired
RJ Bioglan Plant
RJ acquired Malmo's Plant (Sweden) in 2009, with a surface area of 5900 m
Specializing in a manufacturing and development of products used in clinical testing and also semisolid and liquid products; with a manufacturing scale up to 1250 kg.
The swedish Plant also has machinery and facilities for the manufacturing of:
Semisolid forms: ointments, emulsions, microemulsions and creams.
Currently Malmo's produces two lines of packaging; plastic and aluminum tubes and plastic canisters.
Filling and fitting of tubes: 80 units/minute.
Filling and fitting of canisters: 80 units/minute.
Liquids: topical solutions and aerosols
One line for filling and fitting of bottles and tubes
Filling and fitting of canisters: 500 kilograms/hour.
+ More on lyophilization
Designed & Developed by Efecto Muaré
We use own and third-party "cookies" to improve our services and for statistical information of user navigation. If you continue browsing, consider that you accept its use. You can extend this information